Search

Wishlist (0)
0
0

Cart (0)

Wishlist (0)
Home>Dermatology>Buy Zoryve (roflumilast) Online
Zoryve roflumilast

In Stock

Buy Zoryve (roflumilast) Online

Add your review

DISEASE INDICATIONS: Psoriasis

MANUFACTURER: Arcutis Biotherapeutics, Inc.

USAGE: Cutaneous

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Zoryve (roflumilast) is a topical cream used to treat plaque psoriasis in adults and children 12 years of age and older. It works by blocking an enzyme called phosphodiesterase 4 (PDE4), which plays a role in inflammation.

$1,026.40

0.3% of roflumilast x 1 tube of 60 g
Clear
Wishlist
Compare
Tags:,
SKU:344862

Zoryve (roflumilast) description

Zoryve (roflumilast) is a topical cream used to treat plaque psoriasis in adults and children 12 years of age and older. It works by blocking an enzyme called phosphodiesterase 4 (PDE4), which plays a role in inflammation.

Zoryve (roflumilast) uses

Zoryve is used to treat plaque psoriasis, which is the most common type of psoriasis. Plaque psoriasis causes red, raised patches of skin covered with silvery scales. These patches can appear anywhere on the body, but they are most often found on the elbows, knees, scalp, and back.

Zoryve (roflumilast) storage conditions

Zoryve should be stored at room temperature (68°F to 77°F) away from heat, moisture, and direct sunlight. Keep Zoryve out of the reach of children and pets.

Zoryve (roflumilast) mechanism of action

Zoryve works by blocking an enzyme called phosphodiesterase 4 (PDE4). PDE4 is involved in the production of inflammatory chemicals, such as cytokines. By blocking PDE4, Zoryve reduces inflammation and helps to improve the appearance of psoriasis.

Zoryve (roflumilast) how to use

Apply Zoryve to the affected areas of skin once daily. Rub the cream in gently until it is completely absorbed. Wash your hands thoroughly after applying Zoryve.

Zoryve (roflumilast) important safety information

Zoryve may cause serious side effects, including:

  • Allergic reactions, such as hives, difficulty breathing, and swelling of the face, lips, tongue, or throat.
  • Mood or behavior changes, such as anxiety, depression, trouble sleeping, impulsive thoughts, thoughts of self-harm, and rapid and unintended weight loss.
  • Pain or burning when you urinate.
  • Tremors.

If you experience any of these side effects, stop using Zoryve and contact your doctor immediately.

Zoryve (roflumilast) indications

Zoryve is indicated for the topical treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age and older.

Zoryve (roflumilast) precautions

Before using Zoryve, tell your doctor about all of your medical conditions, including:

  • If you have any allergies to medications, including roflumilast.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medications, including over-the-counter medications, herbal supplements, and vitamins.

Zoryve (roflumilast) interactions

Zoryve may interact with other medications, such as:

  • Theophylline
  • Warfarin
  • Metformin
  • Digoxin

Tell your doctor about all of the medications you are taking before you start using Zoryve.

Zoryve (roflumilast) contraindications

Zoryve is contraindicated in patients who are allergic to roflumilast.

Zoryve (roflumilast) overdose

If you accidentally overdose on Zoryve, contact your doctor or poison control center immediately. Symptoms of overdose may include nausea, vomiting, diarrhea, and headache.

Zoryve (roflumilast) side effects

The most common side effects of Zoryve include:

  • Diarrhea
  • Headache
  • Nausea
  • Vomiting
  • Application site reactions, such as burning, itching, and redness

Less common side effects of Zoryve include:

  • Allergic reactions
  • Mood or behavior changes
  • Pain or burning when you urinate
  • Tremors

If you experience any side effects while using Zoryve, talk to your doctor.

Bestsellers

Zoryve roflumilast
Compare
Quick view
Select options

Buy Zoryve (roflumilast) Online

$1,026.40
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Arcutis Biotherapeutics, Inc. USAGE: Cutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Zoryve (roflumilast) is a topical cream used to treat plaque psoriasis in adults and children 12 years of age and older. It works by blocking an enzyme called phosphodiesterase 4 (PDE4), which plays a role in inflammation.
Select options
Compare
Ilumya tildrakizumab
Compare
Quick view
Read more

Buy Ilumya (tildrakizumab) Online

(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Almirall, S.A. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ilumya (tildrakizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the p19 subunit of interleukin-23 (IL-23), a cytokine that plays a key role in the development and progression of psoriasis.
Read more
Compare
Spevigo spesolimab sbzo
Compare
Quick view
Read more

Buy Spevigo (spesolimab-sbzo) Online

(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Boehringer Ingelheim USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Spevigo (spesolimab-sbzo) is a prescription medication used to treat generalized pustular psoriasis (GPP) flares in adults. GPP is a rare autoinflammatory skin disease that can cause painful pustules (blisters) to form all over the body. Spevigo is the first FDA-approved treatment for GPP flares.
Read more
Compare
Skyrizi risankizumab abbvie
Compare
Quick view
Select options

Buy Skyrizi (Risankizumab) Online

From $14,517.47
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: AbbVie Ltd USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) Skyrizi (risankizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the interleukin-23 (IL-23) pathway, which is involved in the development and progression of psoriasis.
Select options
Compare
Compare
Quick view
Select options

Buy Taltz (ixekizumab) Online

From $2,499.58
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.
Select options
Compare
Compare
Quick view
Select options

Buy Cibinqo (abrocitinib) Online

From $1,287.82
(0 Reviews)
DISEASE INDICATIONS: Atopic Dermatitis MANUFACTURER: Pfizer Limited USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Medicines & Healthcare products Regulatory Agency (MHRA) Cibinqo (abrocitinib) is a prescription medicine used to treat adults and children 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that did not respond to other treatment and is not well controlled with prescription medicines, including biologics, or when they cannot be tolerated.
Select options
Compare
Adbry tralokinumab ldrm
Compare
Quick view
Select options

Buy Adbry (tralokinumab-ldrm) Online

$1,283.00
(0 Reviews)
DISEASE INDICATIONS: Atopic Dermatitis MANUFACTURER: Leo Pharma USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Adbry (tralokinumab-ldrm) is a fully human monoclonal antibody that neutralizes the activity of interleukin-13 (IL-13), a cytokine that plays a key role in the pathogenesis of atopic dermatitis. Adbry is approved for the treatment of moderate-to-severe atopic dermatitis (AD) in adults and adolescents 12 years of age and older.
Select options
Compare
Zoryve roflumilast
Compare
Quick view
Select options

Buy Zoryve (roflumilast) Online

$1,026.40
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Arcutis Biotherapeutics, Inc. USAGE: Cutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Zoryve (roflumilast) is a topical cream used to treat plaque psoriasis in adults and children 12 years of age and older. It works by blocking an enzyme called phosphodiesterase 4 (PDE4), which plays a role in inflammation.
Select options
Compare
Ilumya tildrakizumab
Compare
Quick view
Read more

Buy Ilumya (tildrakizumab) Online

(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Almirall, S.A. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ilumya (tildrakizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the p19 subunit of interleukin-23 (IL-23), a cytokine that plays a key role in the development and progression of psoriasis.
Read more
Compare
Spevigo spesolimab sbzo
Compare
Quick view
Read more

Buy Spevigo (spesolimab-sbzo) Online

(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Boehringer Ingelheim USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Spevigo (spesolimab-sbzo) is a prescription medication used to treat generalized pustular psoriasis (GPP) flares in adults. GPP is a rare autoinflammatory skin disease that can cause painful pustules (blisters) to form all over the body. Spevigo is the first FDA-approved treatment for GPP flares.
Read more
Compare
Skyrizi risankizumab abbvie
Compare
Quick view
Select options

Buy Skyrizi (Risankizumab) Online

From $14,517.47
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: AbbVie Ltd USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) Skyrizi (risankizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the interleukin-23 (IL-23) pathway, which is involved in the development and progression of psoriasis.
Select options
Compare
Compare
Quick view
Select options

Buy Taltz (ixekizumab) Online

From $2,499.58
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.
Select options
Compare
Compare
Quick view
Select options

Buy Cibinqo (abrocitinib) Online

From $1,287.82
(0 Reviews)
DISEASE INDICATIONS: Atopic Dermatitis MANUFACTURER: Pfizer Limited USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Medicines & Healthcare products Regulatory Agency (MHRA) Cibinqo (abrocitinib) is a prescription medicine used to treat adults and children 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that did not respond to other treatment and is not well controlled with prescription medicines, including biologics, or when they cannot be tolerated.
Select options
Compare
Adbry tralokinumab ldrm
Compare
Quick view
Select options

Buy Adbry (tralokinumab-ldrm) Online

$1,283.00
(0 Reviews)
DISEASE INDICATIONS: Atopic Dermatitis MANUFACTURER: Leo Pharma USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Adbry (tralokinumab-ldrm) is a fully human monoclonal antibody that neutralizes the activity of interleukin-13 (IL-13), a cytokine that plays a key role in the pathogenesis of atopic dermatitis. Adbry is approved for the treatment of moderate-to-severe atopic dermatitis (AD) in adults and adolescents 12 years of age and older.
Select options
Compare
Zoryve roflumilast
Compare
Quick view
Select options

Buy Zoryve (roflumilast) Online

$1,026.40
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Arcutis Biotherapeutics, Inc. USAGE: Cutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Zoryve (roflumilast) is a topical cream used to treat plaque psoriasis in adults and children 12 years of age and older. It works by blocking an enzyme called phosphodiesterase 4 (PDE4), which plays a role in inflammation.
Select options
Compare
Ilumya tildrakizumab
Compare
Quick view
Read more

Buy Ilumya (tildrakizumab) Online

(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Almirall, S.A. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ilumya (tildrakizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the p19 subunit of interleukin-23 (IL-23), a cytokine that plays a key role in the development and progression of psoriasis.
Read more
Compare
Spevigo spesolimab sbzo
Compare
Quick view
Read more

Buy Spevigo (spesolimab-sbzo) Online

(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Boehringer Ingelheim USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Spevigo (spesolimab-sbzo) is a prescription medication used to treat generalized pustular psoriasis (GPP) flares in adults. GPP is a rare autoinflammatory skin disease that can cause painful pustules (blisters) to form all over the body. Spevigo is the first FDA-approved treatment for GPP flares.
Read more
Compare

Back to Top
Product has been added to your cart
Close